Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma

被引：7
|
作者：
Miron, Benjamin [1 ]
Geynisman, Daniel M. [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA USA
来源：
EUROPEAN UROLOGY | 2022年 / 82卷 / 04期
关键词：
CHEMOTHERAPY; CISPLATIN; MULTICENTER;
D O I：
10.1016/j.eururo.2022.05.023
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：374 / 376
页数：3
相关论文
共 50 条
  • [1] Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02
    Siefker-Radtke, Arlene O.
    Cho, Daniel C.
    Diab, Adi
    Sznol, Mario
    Bilen, Mehmet A.
    Balar, Arjun, V
    Grignani, Giovanni
    Puente, Erika
    Tang, Lily
    Chien, David
    Hoch, Ute
    Choudhury, Arkopal
    Yu, Danni
    Currie, Sue L.
    Tagliaferri, Mary A.
    Zalevsky, Jonathan
    Hurwitz, Michael E.
    Tannir, Nizar M.
    EUROPEAN UROLOGY, 2022, 82 (04) : 365 - 373
  • [2] Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma
    Diab, Adi
    Tykodi, Scott S.
    Daniels, Gregory A.
    Maio, Michele
    Curti, Brendan D.
    Lewis, Karl D.
    Jang, Sekwon
    Kalinka, Ewa
    Puzanov, Igor
    Spira, Alexander, I
    Cho, Daniel C.
    Guan, Shanhong
    Puente, Erika
    Tuan Nguyen
    Hoch, Ute
    Currie, Sue L.
    Lin, Wei
    Tagliaferri, Mary A.
    Zalevsky, Jonathan
    Sznol, Mario
    Hurwitz, Michael E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (26) : 2914 - +
  • [3] First-line treatment of metastatic urothelial carcinoma: an update
    von Amsberg, Gunhild
    Retz, Margitta
    De Santis, Maria
    Niegisch, Gunter
    ONKOLOGIE, 2022, 28 (09): : 792 - 798
  • [4] Gemcitabine with cisplatin and nivolumab: Redefining standard of care for first-line metastatic urothelial carcinoma?
    Thomas, Vinay Mathew
    Grivas, Petros
    Agarwal, Neeraj
    MED, 2024, 5 (02): : 109 - 111
  • [5] First-line Immunotherapy in Metastatic Urothelial Carcinoma
    Ghatalia, Pooja
    Zibelman, Matthew
    Geynisman, Daniel M.
    Plimack, Elizabeth R.
    EUROPEAN UROLOGY FOCUS, 2020, 6 (01): : 45 - 47
  • [6] Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
    Tassinari, Elisa
    Mollica, Veronica
    Nuvola, Giacomo
    Marchetti, Andrea
    Rosellini, Matteo
    Massari, Francesco
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1945 - 1960
  • [7] Medical oncologists' first-line treatment preferences in metastatic urothelial carcinoma
    Apolo, Andrea B.
    Cambron-Mellott, M. Janelle
    Beusterien, Kathleen
    Seal, Brian S.
    Maculaitis, Martine C.
    Bernstein, Andrew
    Epperson, Megan
    Jeffress, Mara Lisa
    Doleh, Yunes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
    E. El Rassy
    T. Assi
    Z. Bakouny
    N. Pavlidis
    J. Kattan
    Clinical and Translational Oncology, 2019, 21 : 280 - 288
  • [9] Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
    El Rassy, E.
    Assi, T.
    Bakouny, Z.
    Pavlidis, N.
    Kattan, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03): : 280 - 288
  • [10] First-line treatment of metastatic urothelial carcinoma Update immuno-oncology
    Zacharis, A.
    Gruellich, C.
    UROLOGE, 2020, 59 (07): : 797 - 803
12345